Replies to post #413 on Bottom Fish Stocks (between .10 and$10)

[zenvesting]

Stuart re: BIPH,

I hope I'm not being to liberal in connecting these dots; but it sure is interesting that Biophan/Nanoset just discovered (and patented) how their nanomagnetic coatings have drug-eluting properties, while doing R&D with Boston Scientific, who has 75% market share in drug-eluting stents.

Even more interesting to me is that they presented this information during a panel discussion with ANPI today, who is BSXs current liscensor of the drug-eluting tech. for the Taxus stent. If nothing else, the joint-presentation with ANPI at least validates BIPHs claims. But I really think BIPH and ANPI might have a bit more of a relationship/colaboration under the veil of BSX non-disclosure agreements.

I don't know why the market didn't get a little more excited about it; but I sure am.

I'll stop chearleading for now.....and wait patiently for the day when the BSX R&D becomes more transparent.

Good luck!